Lyon, France — Global Access International On-Site Regenerative Treatment Program
- Dr. Andrew Peskau
- Mar 1, 2025
- 2 min read
Location: Lyon, France
Program: Global Access — On-Site Regenerative Treatment
Patient: Adult patient (identity undisclosed)
Diagnosis: Amyotrophic lateral sclerosis (ALS)
Overview
As part of the Global Access program, the BioCells Medical medical team traveled to Lyon, France, to deliver an individualized regenerative treatment protocol directly at the patient’s location.
This format is intended for patients who require advanced medical care and structured supervision while receiving treatment outside a clinical inpatient environment.
Medical Rationale
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder characterized by motor neuron degeneration, neuroinflammation, and progressive functional decline.
The objective of this intervention was to support neuromuscular function, modulate inflammatory activity, and preserve functional capacity through a science-based regenerative approach under medical supervision.
Treatment Protocol (Personalized)
Based on pre-treatment medical evaluation and clinical documentation, the protocol included:
Mesenchymal Stem Cell therapy (MSC) Applied to support neuroprotective and immunomodulatory mechanisms relevant to motor neuron degeneration.
T-regulatory therapy Used to support immune regulation and reduce chronic neuroinflammatory processes.
Concentrated purified exosomes Integrated as a regenerative support component involved in intercellular signaling and tissue-support pathways.
Supportive neurofunctional therapy Included as part of post-intervention functional support and adaptation.
Targeted peptide therapy and neurostimulation were not included in this protocol, as they were not clinically indicated for this patient profile.
Treatment Delivery
All procedures were performed by BioCells Medical specialists in accordance with internal clinical protocols and international medical standards.
The treatment session was completed successfully, without complications.
Post-Treatment Monitoring & Rehabilitation
Following the intervention:
A dedicated rehabilitation specialist has been assigned to the patient
Structured follow-up monitoring has been initiated
Clinical observations and progress indicators are being systematically documented
The patient remains under continuous medical supervision during the follow-up phase.
Global Access Program — BioCells Medical
The Global Access model enables BioCells Medical to deliver advanced regenerative therapies internationally by combining:
Mobile medical teams
In-house certified laboratory processing
Diagnosis-driven, individually adjusted treatment protocols
This approach ensures continuity of care while respecting patient-specific medical and logistical requirements.
Request a Medical Consultation
BioCells Medical provides international on-site regenerative treatment through its Global Access program.
During the consultation, our medical team reviews your medical records, diagnosis, and clinical history to determine whether Global Access is medically appropriate for your case and whether a personalized treatment protocol can be formulated.
